Genetic predictors of cervical dysplasia in African American HIV-infected women

ACTG DACS 268

Michelle Cespedes, Sarah Kerns, Robert Holzman, Paul McLaren, Harry Ostrer, Judith Aberg

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: To examine genome-wide associations in HIV-infected women with a history of cervical dysplasia compared with HIV-infected women with no history of abnormal Papanicolaou (Pap) tests. Design: Case-control study using data from women analyzed for the HIV Controllers Study and enrolled in HIV treatment-naïve studies in the AIDS Clinical Trials Group (ACTG). Methods: Genotyping utilized Illumina HumanHap 650 Y or 1MDuo platforms. After quality control and principal component analysis, ~610,000 significant single nucleotide polymorphisms (SNPs) were tested for association. Threshold for significance was P < 5 × 10<sup>-8</sup> for genome-wide associations. Results: No significant genomic association was observed between women with low-grade dysplasia and controls. The genome-wide association study (GWAS) analysis between women with high-grade dysplasia or invasive cervical cancer and normal controls identified significant SNPs. In the analyses limited to African American women, 11 SNPs were significantly associated with the development of high-grade dysplasia or cancer after correcting for multiple comparisons. The model using significant SNPs alone had improved accuracy in predicting high-grade dysplasia in African American women compared to the use of clinical data (area under the receiver operating characteristic curve for genetic and clinical model = 0.9 and 0.747, respectively). Conclusions: These preliminary data serve as proof of concept that there may be a genetic predisposition to developing high-grade cervical dysplasia in African American HIV-infected women. Given the small sample size, the results need to be validated in a separate cohort.

Original languageEnglish (US)
Pages (from-to)292-302
Number of pages11
JournalHIV Clinical Trials
Volume14
Issue number6
DOIs
StatePublished - Jan 1 2013

Fingerprint

Uterine Cervical Dysplasia
African Americans
Acquired Immunodeficiency Syndrome
Clinical Trials
HIV
Single Nucleotide Polymorphism
Genome-Wide Association Study
Genome
Papanicolaou Test
Genetic Models
Genetic Predisposition to Disease
Principal Component Analysis
ROC Curve
Uterine Cervical Neoplasms
Quality Control
Sample Size
Case-Control Studies

Keywords

  • cervical dysplasia
  • GWAS
  • risk markers

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Genetic predictors of cervical dysplasia in African American HIV-infected women : ACTG DACS 268. / Cespedes, Michelle; Kerns, Sarah; Holzman, Robert; McLaren, Paul; Ostrer, Harry; Aberg, Judith.

In: HIV Clinical Trials, Vol. 14, No. 6, 01.01.2013, p. 292-302.

Research output: Contribution to journalArticle

Cespedes, Michelle ; Kerns, Sarah ; Holzman, Robert ; McLaren, Paul ; Ostrer, Harry ; Aberg, Judith. / Genetic predictors of cervical dysplasia in African American HIV-infected women : ACTG DACS 268. In: HIV Clinical Trials. 2013 ; Vol. 14, No. 6. pp. 292-302.
@article{be5411b37774428e8170019609c5295f,
title = "Genetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268",
abstract = "Objective: To examine genome-wide associations in HIV-infected women with a history of cervical dysplasia compared with HIV-infected women with no history of abnormal Papanicolaou (Pap) tests. Design: Case-control study using data from women analyzed for the HIV Controllers Study and enrolled in HIV treatment-na{\"i}ve studies in the AIDS Clinical Trials Group (ACTG). Methods: Genotyping utilized Illumina HumanHap 650 Y or 1MDuo platforms. After quality control and principal component analysis, ~610,000 significant single nucleotide polymorphisms (SNPs) were tested for association. Threshold for significance was P < 5 × 10-8 for genome-wide associations. Results: No significant genomic association was observed between women with low-grade dysplasia and controls. The genome-wide association study (GWAS) analysis between women with high-grade dysplasia or invasive cervical cancer and normal controls identified significant SNPs. In the analyses limited to African American women, 11 SNPs were significantly associated with the development of high-grade dysplasia or cancer after correcting for multiple comparisons. The model using significant SNPs alone had improved accuracy in predicting high-grade dysplasia in African American women compared to the use of clinical data (area under the receiver operating characteristic curve for genetic and clinical model = 0.9 and 0.747, respectively). Conclusions: These preliminary data serve as proof of concept that there may be a genetic predisposition to developing high-grade cervical dysplasia in African American HIV-infected women. Given the small sample size, the results need to be validated in a separate cohort.",
keywords = "cervical dysplasia, GWAS, risk markers",
author = "Michelle Cespedes and Sarah Kerns and Robert Holzman and Paul McLaren and Harry Ostrer and Judith Aberg",
year = "2013",
month = "1",
day = "1",
doi = "10.1310/hct1406-292",
language = "English (US)",
volume = "14",
pages = "292--302",
journal = "HIV Clinical Trials",
issn = "1528-4336",
publisher = "Thomas Land Publishers Inc.",
number = "6",

}

TY - JOUR

T1 - Genetic predictors of cervical dysplasia in African American HIV-infected women

T2 - ACTG DACS 268

AU - Cespedes, Michelle

AU - Kerns, Sarah

AU - Holzman, Robert

AU - McLaren, Paul

AU - Ostrer, Harry

AU - Aberg, Judith

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Objective: To examine genome-wide associations in HIV-infected women with a history of cervical dysplasia compared with HIV-infected women with no history of abnormal Papanicolaou (Pap) tests. Design: Case-control study using data from women analyzed for the HIV Controllers Study and enrolled in HIV treatment-naïve studies in the AIDS Clinical Trials Group (ACTG). Methods: Genotyping utilized Illumina HumanHap 650 Y or 1MDuo platforms. After quality control and principal component analysis, ~610,000 significant single nucleotide polymorphisms (SNPs) were tested for association. Threshold for significance was P < 5 × 10-8 for genome-wide associations. Results: No significant genomic association was observed between women with low-grade dysplasia and controls. The genome-wide association study (GWAS) analysis between women with high-grade dysplasia or invasive cervical cancer and normal controls identified significant SNPs. In the analyses limited to African American women, 11 SNPs were significantly associated with the development of high-grade dysplasia or cancer after correcting for multiple comparisons. The model using significant SNPs alone had improved accuracy in predicting high-grade dysplasia in African American women compared to the use of clinical data (area under the receiver operating characteristic curve for genetic and clinical model = 0.9 and 0.747, respectively). Conclusions: These preliminary data serve as proof of concept that there may be a genetic predisposition to developing high-grade cervical dysplasia in African American HIV-infected women. Given the small sample size, the results need to be validated in a separate cohort.

AB - Objective: To examine genome-wide associations in HIV-infected women with a history of cervical dysplasia compared with HIV-infected women with no history of abnormal Papanicolaou (Pap) tests. Design: Case-control study using data from women analyzed for the HIV Controllers Study and enrolled in HIV treatment-naïve studies in the AIDS Clinical Trials Group (ACTG). Methods: Genotyping utilized Illumina HumanHap 650 Y or 1MDuo platforms. After quality control and principal component analysis, ~610,000 significant single nucleotide polymorphisms (SNPs) were tested for association. Threshold for significance was P < 5 × 10-8 for genome-wide associations. Results: No significant genomic association was observed between women with low-grade dysplasia and controls. The genome-wide association study (GWAS) analysis between women with high-grade dysplasia or invasive cervical cancer and normal controls identified significant SNPs. In the analyses limited to African American women, 11 SNPs were significantly associated with the development of high-grade dysplasia or cancer after correcting for multiple comparisons. The model using significant SNPs alone had improved accuracy in predicting high-grade dysplasia in African American women compared to the use of clinical data (area under the receiver operating characteristic curve for genetic and clinical model = 0.9 and 0.747, respectively). Conclusions: These preliminary data serve as proof of concept that there may be a genetic predisposition to developing high-grade cervical dysplasia in African American HIV-infected women. Given the small sample size, the results need to be validated in a separate cohort.

KW - cervical dysplasia

KW - GWAS

KW - risk markers

UR - http://www.scopus.com/inward/record.url?scp=84890521035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890521035&partnerID=8YFLogxK

U2 - 10.1310/hct1406-292

DO - 10.1310/hct1406-292

M3 - Article

VL - 14

SP - 292

EP - 302

JO - HIV Clinical Trials

JF - HIV Clinical Trials

SN - 1528-4336

IS - 6

ER -